Siegel Jordan I 4
4 · NABI BIOPHARMACEUTICALS · Filed Jun 13, 2006
Insider Transaction Report
Form 4
Siegel Jordan I
Sr. VP, Fin, CFO, CAO & Treas.
Transactions
- Award
Common Stock
2006-06-12+60,000→ 60,000 total - Award
Stock Option (right to buy)
2006-06-12+40,000→ 40,000 totalExercise: $5.10Exp: 2013-06-12→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]Restricted stock that vests in full on June 12, 2009.
- [F2]The option becomes exercisable in four equal annual installments beginning on the first anniversary of the grant date specified in column 3.